Tecnovatica S.A. (WSE:TEC)

Poland flag Poland · Delayed Price · Currency is PLN
0.4080
-0.0060 (-1.45%)
At close: Feb 11, 2026
Market Cap4.39M -17.7%
Revenue (ttm)52.62K +163.1%
Net Income69.77K
EPS0.01
Shares Out10.75M
PE Ratio62.86
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,309
Average Volume38,465
Open0.4100
Previous Close0.4140
Day's Range0.3760 - 0.4100
52-Week Range0.2280 - 1.1850
Beta-0.22
RSI81.84
Earnings DateMar 20, 2026

About Tecnovatica

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Employees 1
Stock Exchange Warsaw Stock Exchange
Ticker Symbol TEC
Full Company Profile